| 臺大學術典藏 |
2020-04-10T12:51:16Z |
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
|
Hsu C.-H.; Hu F.-C.; Hsu C.-Y. ;Shen Y.-C. ;Yu C.-W. ;Chiun Hsu ;Hu F.-C. ;Hsu C.-H. ;Chen B.-B. ;Wei S.-Y. ;Cheng A.-L. ;Shih T.T.-F.; Hsu C.-Y.; Shen Y.-C.; Yu C.-W.; Chiun Hsu; Chen B.-B.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2011 |
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
|
Yu C.-W.; Hsu C.; Hu F.-C.; CHIH-HUNG HSU; Chen B.-B.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F.; Shen Y.-C.; Hsu C.-Y.; Hsu C.-Y. ;Shen Y.-C. ;Yu C.-W. ;Hsu C. ;Hu F.-C. ;Chih-Hung Hsu ;Chen B.-B. ;Wei S.-Y. ;Cheng A.-L. ;Shih T.T.-F. |
| 臺大學術典藏 |
2020-07-09T02:57:04Z |
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
|
Hsu C.-H.; Chen B.-B.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F.; Hsu C.-Y. ;Shen Y.-C. ;Chih-Wei Yu ;Hsu C. ;Hu F.-C. ;Hsu C.-H. ;Chen B.-B. ;Wei S.-Y. ;Cheng A.-L. ;Shih T.T.-F.; Hsu C.-Y.; Shen Y.-C.; CHIH-WEI YU; Hsu C.; Hu F.-C. |
| 臺大學術典藏 |
2020-09-22T07:39:54Z |
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
|
Chao-Yu Hsu ;Shen Y.-C. ;Yu C.-W. ;Hsu C. ;Hu F.-C. ;Hsu C.-H. ;Chen B.-B. ;Wei S.-Y. ;Cheng A.-L. ;Shih T.T.-F.; CHAO-YU HSU; Shen Y.-C.; Yu C.-W.; Hsu C.; Hu F.-C.; Hsu C.-H.; Chen B.-B.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2021-09-01T01:54:06Z |
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
|
Hsu C.-Y.; Shen Y.-C.; Yu C.-W.; Hsu C.; Hu F.-C.; Hsu C.-H.; Chen B.-B.; Wei S.-Y.; ANN-LII CHENG; Shih T.T.-F. |
| 國立臺灣大學 |
2012 |
Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients
|
Chen, Bang-Bin; Hsu, Chao-Yu; Yu, Chih-Wei; Wei, Shwu-Yuan; Kao, Jia-Horng; Lee, Hsuan-Shu; Shih, Tiffany Ting-Fang; 高嘉宏; 施庭芳; 許昭禹; 陳邦斌; 魏淑圓; 李宣書; 游治維 |
| 臺大學術典藏 |
2018-09-10T09:14:51Z |
Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients
|
Chen, B.-B. and Hsu, C.-Y. and Yu, C.-W. and Wei, S.-Y. and Kao, J.-H. and Lee, H.-S. and Shih, T.T.-F.; Chen, Bang-Bin;Hsu, Chao-Yu;Yu, Chih-Wei;Wei, Shwu-Yuan;Kao, Jia-Horng;Lee, Hsuan-Shu;Shih, Tiffany Ting-Fang; 高嘉宏 ;施庭芳 ;許昭禹 ;陳邦斌 ;魏淑圓 ;李宣書 ;游治維; TIFFANY TING-FANG SHIH; Chen, Bang-Bin; Chen, Bang-Bin; HSUAN-SHU LEE; Hsu, Chao-Yu; Hsu, Chao-Yu; Yu, Chih-Wei; CHAO-YU HSU; Yu, Chih-Wei; BANG-BIN CHEN; Wei, Shwu-Yuan; CHIH-WEI YU; Kao, Jia-Horng; Kao, Jia-Horng; Lee, Hsuan-Shu; JIA-HORNG KAO; Shih, Tiffany Ting-Fang |
| 臺大學術典藏 |
2020-07-09T02:57:04Z |
Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients
|
Shih T.T.-F.; Lee H.-S.; Kao J.-H.; Wei S.-Y.; CHIH-WEI YU; Hsu C.-Y.; Chen B.-B. |
| 臺大學術典藏 |
2020-08-06T07:51:55Z |
Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Wei S.-Y.; Kao J.-H.; Lee H.-S.; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2020-09-22T07:39:54Z |
Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients
|
Shih T.T.-F.; Lee H.-S.; Kao J.-H.; Wei S.-Y.; Chen B.-B.; CHAO-YU HSU; Yu C.-W. |
| 臺大學術典藏 |
2021-02-02T06:40:57Z |
Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Wei S.-Y.; Kao J.-H.; Lee, Hsuan-Shu; Shih T.T.-F.; Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Wei S.-Y.; Kao J.-H.; Lee, Hsuan-Shu; Shih T.T.-F. |
| 臺大學術典藏 |
2021-09-04T06:12:04Z |
Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Wei S.-Y.; JIA-HORNG KAO; Lee H.-S.; Shih T.T.-F. |
| 國立臺北護理健康大學 |
2011 |
Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission
|
劉介宇; Chen, Bang-Bin;Hsu, Chao-Yu;Yu, Chih-Wei;Hou, Hsin-An;Liu, Chieh-Yu;Wei, Shwu-Yuan;Chou, Wen-Chien;Tien, Hwei-Fang;Tiffany Shih, Ting-Fang |
| 臺大學術典藏 |
2018-09-10T08:43:44Z |
Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission
|
Chen, B.-B. and Hsu, C.-Y. and Yu, C.-W. and Hou, H.-A. and Liu, C.-Y. and Wei, S.-Y. and Chou, W.-C. and Tien, H.-F. and Shih, T.T.-F.; TIFFANY TING-FANG SHIH; CHAO-YU HSU; HWEI-FANG TIEN; WEN-CHIEN CHOU; HSIN-AN HOU; BANG-BIN CHEN; CHIH-WEI YU |
| 臺大學術典藏 |
2020-07-09T02:57:05Z |
Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission
|
Wei S.-Y.; Chou W.-C.; Tien H.-F.; Shih T.T.-F.; Chen B.-B.;Hsu C.-Y.;Chih-Wei Yu;Hou H.-A.;Liu C.-Y.;Wei S.-Y.;Chou W.-C.;Tien H.-F.;Shih T.T.-F.; Chen B.-B.; Hsu C.-Y.; CHIH-WEI YU; Hou H.-A.; Liu C.-Y. |
| 臺大學術典藏 |
2011 |
Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission
|
Wei S.-Y.; Chou W.-C.; Tien H.-F.; Shih T.T.-F.; Liu C.-Y.; Hou H.-A.; Yu C.-W.; Hsu C.-Y.; BANG-BIN CHEN; Bang-Bin Chen;Hsu C.-Y.;Yu C.-W.;Hou H.-A.;Liu C.-Y.;Wei S.-Y.;Chou W.-C.;Tien H.-F.;Shih T.T.-F. |
| 臺大學術典藏 |
2020-09-22T07:39:55Z |
Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission
|
Shih T.T.-F.; Tien H.-F.; Chou W.-C.; Wei S.-Y.; Liu C.-Y.; Hou H.-A.; Yu C.-W.; CHAO-YU HSU; Chen B.-B.; Chen B.-B. ;Chao-Yu Hsu ;Yu C.-W. ;Hou H.-A. ;Liu C.-Y. ;Wei S.-Y. ;Chou W.-C. ;Tien H.-F. ;Shih T.T.-F. |
| 臺大學術典藏 |
2020-08-06T07:51:57Z |
Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission
|
Wei S.-Y.; Chou W.-C.; Tien H.-F.; TIFFANY TING-FANG SHIH; Liu C.-Y.; Hou H.-A.; Yu C.-W.; Hsu C.-Y.; Chen B.-B. |
| 臺大學術典藏 |
2021-02-05T06:29:40Z |
Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission
|
Chen B.-B.;Hsu C.-Y.;Yu C.-W.;Hou H.-A.;Liu C.-Y.;Wei S.-Y.;Wen-Chien Chou;Tien H.-F.;Shih T.T.-F.; Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Hou H.-A.; Liu C.-Y.; Wei S.-Y.; WEN-CHIEN CHOU; Tien H.-F.; Shih T.T.-F. |
| 臺大學術典藏 |
2011 |
Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission
|
Shih T.T.-F.; HWEI-FANG TIEN; Chou W.-C.; Wei S.-Y.; Hou H.-A.; Liu C.-Y.; Hsu C.-Y.; Yu C.-W.; Chen B.-B. |
| 臺大學術典藏 |
2022-01-12T07:07:40Z |
Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; HSIN-AN HOU; Liu C.-Y.; Wei S.-Y.; Chou W.-C.; Tien H.-F.; Shih T.T.-F. |
| 臺大學術典藏 |
2022-08-19T00:20:44Z |
Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Liang P.-C.; CHIUN HSU; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
| 國立臺灣大學 |
2016 |
Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy
|
Chen, Bang-Bin; Hsu, Chao-Yu; Yu, Chih-Wei; Liang, Po-Chin; Hsu, Chiun; Hsu, Chih-Hung; Cheng, Ann-Lii; Shih, Tiffany Ting-Fang; 許昭禹; 鄭安理; 陳邦斌; 徐志宏; 許駿; 梁博欽; 游治維 |
| 臺大學術典藏 |
2020-04-10T12:51:04Z |
Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy
|
Shih T.T.-F.; Cheng A.-L.; Hsu C.-H.; Chiun Hsu; Liang P.-C.; Chen B.-B.;Hsu C.-Y.;Yu C.-W.;Liang P.-C.;Chiun Hsu;Hsu C.-H.;Cheng A.-L.;Shih T.T.-F.; Chen B.-B.; Hsu C.-Y.; Yu C.-W. |
| 臺大學術典藏 |
2020-07-09T02:57:02Z |
Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy
|
Chen B.-B.; Hsu C.-Y.; CHIH-WEI YU; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-08-06T07:51:46Z |
Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2020-09-22T07:39:51Z |
Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy
|
Shih T.T.-F.; Cheng A.-L.; Hsu C.-H.; Hsu C.; Liang P.-C.; Chen B.-B.; CHAO-YU HSU; Yu C.-W. |
| 臺大學術典藏 |
2020-08-11T08:36:45Z |
Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; PO-CHIN LIANG; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2021-08-31T06:29:46Z |
Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Liang P.-C.; Hsu C.; Hsu C.-H.; ANN-LII CHENG; Shih T.T.-F. |
| 國家衛生研究院 |
2004-09 |
Dynamic contrast-enhanced MRI analysis of perfusion changes in advanced hepatocellular carcinoma treated with an antiangiogenic agent: A preliminary study
|
Wang, J; Chen, LT; Tsang, YM; Liu, TW; Shih, TTF |
| 國立臺灣大學 |
2004 |
Dynamic Contrast-Enhanced Mri Analysis of Perfusion Changes in Advanced Hepatocellular Carcinoma Treated with an Antiangiogenic Agent: A Preliminary Study
|
王甄; 陳立宗; 曾旭明; 劉滄梧; 施庭芳; WANG, JANE; CHEN, LI-TZONG; TSANG, YUK-MING; LIU, TSANG-WU; SHIH, TIFFANY TING-FANG |
| 臺大學術典藏 |
2018-09-10T04:44:34Z |
Dynamic contrast-enhanced MRI analysis of perfusion changes in advanced hepatocellular carcinoma treated with an antiangiogenic agent: A preliminary study
|
Wang, J. and Chen, L.-T. and Tsang, Y.-M. and Liu, T.-W. and Shih, T.T.-F.; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2004 |
Dynamic contrast-enhanced MRI analysis of perfusion changes in advanced hepatocellular carcinoma treated with an antiangiogenic agent: A preliminary study
|
TIFFANY TING-FANG SHIH; Liu T.-W.; Tsang Y.-M.; Chen L.-T.; Wang J.; Wang J.;Chen L.-T.;Tsang Y.-M.;Liu T.-W.;Tiffany Ting-Fang Shih |
| 臺北醫學大學 |
2005 |
Dynamic Contrast-enhanced MRI Assessment of Patellar Perfusion in ACL-resected Model for Early Chondromalacia Patellae Perfusion in Rabbits: Preliminary Report.
|
陳榮邦; Chan WP; Kuo TF; Huang GS; Wu YL; Lin MF; Liu YJ |
| 國立臺灣大學 |
2012 |
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
|
Chang, Yeun-Chung; Yu, Chong-Jen; Chen, Chung-Ming; Hu, Fu-Chang; Hsu, Hao-Hsiang; Tseng, Wen-Yih I.; Shih, Tiffany Ting-Fang; Yang, Pan-Chyr; Yang, James Chih-Hsin; 曾文毅; 楊志新; 陳中明; 張允中; 施庭芳; 楊泮池; 余忠仁; 胡賦強 |
| 臺大學術典藏 |
2018-09-10T09:15:12Z |
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
|
Chang, Yeun-Chung; Yu, Chong-Jen; Chen, Chung-Ming; Hu, Fu-Chang; Hsu, Hao-Hsiang; Tseng, Wen-Yih I.; Shih, Tiffany Ting-Fang; Yang, Pan-Chyr; Yang, James Chih-Hsin曾文毅; 楊志新; 陳中明; 張允中; 施庭芳; 楊泮池; 余忠仁; 胡賦強; 曾文毅; 楊志新; 陳中明; 張允中; 施庭芳; 楊泮池; 余忠仁; 胡賦強Chang, Y.-C.; Yu, C.-J.; Chen, C.-M.; Hu, F.-C.; Hsu, H.-H.; Tseng, W.-Y.I.; Ting-Fang Shih, T.; Yang, P.-C.; Chih-Hsin Yang, J.; 楊泮池; Chang, Yeun-Chung; TIFFANY TING-FANG SHIH; Yu, Chong-Jen; Chen, Chung-Ming; CHONG-JEN YU; Yang, Pan-Chyr |
| 臺大學術典藏 |
2020-03-03T03:06:39Z |
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
|
Chang Y.-C.; Yu C.-J.; Chen C.-M.; Hu F.-C.; Hsu H.-H.; WEN-YIH TSENG; Ting-Fang Shih T.; Yang P.-C.; Chih-Hsin Yang J. |
| 臺大學術典藏 |
2012 |
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
|
Chang Y.-C.; Yu C.-J.; Chen C.-M.; Hu F.-C.; Hsu H.-H.; Tseng W.-Y.I.; TIFFANY TING-FANG SHIH; Yang P.-C.; Chih-Hsin Yang J. |
| 臺大學術典藏 |
2020-05-26T09:27:05Z |
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
|
Chih-Hsin Yang;Yang P.-C;Ting-Fang Shih T;Tseng W.-Y.I;Hsu H.-H;Hu F.-C;Chen C.-M;Yu C.-J;Chang Y.-C; Chang Y.-C; Yu C.-J; Chen C.-M; Hu F.-C; Hsu H.-H; Tseng W.-Y.I; Ting-Fang Shih T; Yang P.-C; Chih-Hsin CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-12-02T02:33:57Z |
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
|
Chang Y.-C.; Yu C.-J.; Chen C.-M.; Hu F.-C.; Hsu H.-H.; Tseng W.-Y.I.; Ting-Fang Shih T.; Pan-Chyr Yang; Chih-Hsin Yang J.; Chang Y.-C.; Yu C.-J.; Chen C.-M.; Hu F.-C.; Hsu H.-H.; Tseng W.-Y.I.; Ting-Fang Shih T.; PAN-CHYR YANG; Chih-Hsin Yang J. |
| 臺大學術典藏 |
2021-03-19T06:57:41Z |
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
|
YEUN-CHUNG CHANG; Yu C.-J.; Chen C.-M.; Hu F.-C.; Hsu H.-H.; Tseng W.-Y.I.; Ting-Fang Shih T.; Yang P.-C.; Chih-Hsin Yang J. |
| 臺大學術典藏 |
2022-06-27T07:02:05Z |
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
|
Chang Y.-C.; CHONG-JEN YU; Chen C.-M.; Hu F.-C.; Hsu H.-H.; Tseng W.-Y.I.; Ting-Fang Shih T.; Yang P.-C.; Chih-Hsin Yang J. |
| 臺北醫學大學 |
2000 |
Dynamic Contrast-enhanced MRI in Assessment of Femoral Head Osteonecrosis
|
陳榮邦; 黃瑞香; 林明芳; 劉益瑞; 江清泉 |
| 臺北醫學大學 |
1998 |
Dynamic Contrast-enhanced MRI in Early AVN of the Hip: Comparison of Native versus Post-processing Subtraction Method.
|
陳榮邦; Lin MF; Chan WP; Liu Y-J; Jiang C-C |
| 臺大學術典藏 |
1998 |
Dynamic control and indirect absorption detection for high-speed capillary electrophoretic separation of organic acids
|
Chang, Huan-Tsung; Chen, Hsuan-Shen; Lee, Richard; Chang, Huan-Tsung; Chen, Hsuan-Shen; Lee, Richard |
| 國立臺灣大學 |
1998 |
Dynamic control and indirect absorption detection for high-speed capillary electrophoretic separation of organic acids
|
Chang, Huan-Tsung; Chen, Hsuan-Shen; Lee, Richard |
| 輔英科技大學 |
1997-11-26 |
Dynamic control for the separation of
|
謝明穆 |
| 輔英科技大學 |
1998-01-09 |
Dynamic control for the separation of organic acids in capillary electrophoresis
|
Hsieh,Ming-Mu ;Chang,Huan-Tsung |
| 輔英科技大學 |
1997-05-20 |
Dynamic control for the separation of organic acids in capillary electrophoresis
|
謝明穆 |
| 國立臺灣大學 |
1998 |
Dynamic control for the separation of organic acids in capillary Electrophoresis
|
Hsieh, Ming-Mu; Chang, Huan-Tsung |
